Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-03 4:00 pm Purchase | 2026-07-27 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Perceptive Advisors LLC | 266,756 9.990% | 264,061 (+9798.18%) | Filing History |
| 2026-07-23 4:00 pm Purchase | 2026-07-20 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Perceptive Advisors LLC | 10,871,847 10.100% | 10,871,847 (New Position) | Filing History |
| 2026-07-20 4:00 pm Purchase | 2026-07-13 | 13G | RESEARCH ALLIANCE CORP IV RACD | Perceptive Advisors LLC | 700,000 7.700% | 700,000 (New Position) | Filing History |
| 2026-06-25 4:00 pm Purchase | 2026-06-18 | 13D | KARDIGAN INC KARD | Perceptive Advisors LLC | 8,254,144 8.900% | 8,254,144 (New Position) | Filing History |
| 2026-05-28 4:00 pm Purchase | 2026-05-20 | 13G | RESEARCH ALLIANCE CORP III CL RACC | Perceptive Advisors LLC | 750,000 8.200% | 750,000 (New Position) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Perceptive Advisors LLC | 3,519,626 5.100% | -903,815 (-20.43%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 979,815 6.100% | 92,928 (+10.48%) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Perceptive Advisors LLC | 8,284,882 7.500% | -667,483 (-7.46%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | BIODESIX INC BDSX | Perceptive Advisors LLC | 483,694 4.600% | 100,000 (+26.06%) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | INHIBRX BIOSCIENCES INC INBX | Perceptive Advisors LLC | 1,461,105 9.990% | -27,448 (-1.84%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | X4 PHARMACEUTICALS INC XFOR | Perceptive Advisors LLC | 6,889,163 7.300% | 824,483 (+13.59%) | Filing History |
| 2026-05-15 4:00 pm Unchanged | 2026-03-31 | 13G | ADAGIO MED INC ADGM | Perceptive Advisors LLC | 15,321,655 55.400% | 0 (Unchanged) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | PALISADE BIO INC COM P PALI | Perceptive Advisors LLC | 14,113,863 7.900% | -1,086,254 (-7.15%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | Perceptive Advisors LLC | 8,830,145 9.990% | 1,655,991 (+23.08%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Perceptive Advisors LLC | 10,098,824 4.600% | 418,639 (+4.32%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 1,447,782 5.500% | 878,474 (+154.31%) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | ALDEYRA THERAPEUTICS, INC ALDX | Perceptive Advisors LLC | 0 0.000% | -4,185,632 (Position Closed) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | ENVVENO MED CORP COM NVNO | Perceptive Advisors LLC | 68,525 9.990% | -1,979,990 (-96.65%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Perceptive Advisors LLC | 6,431,743 8.400% | 2,959,882 (+85.25%) | Filing History |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Perceptive Advisors LLC | 12,635,875 8.900% | -180,768 (-1.41%) | Filing History |